Harrow, Inc. (HROW)

NASDAQ: HROW · Real-Time Price · USD

33.45

+0.03 (0.09%)

At close: Aug 5, 2025, 4:00 PM

34.00

+0.55 (1.64%)

After-hours: Aug 5, 2025, 7:15 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Innovative Ophthalmic Therapies	130.19M	Log In	Log In	Log In	Log In	Upgrade
Innovative Ophthalmic Therapies Growth	46.95%	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Compounding	-	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Compounding Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	130.19M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	46.95%	Log In	Log In	Log In	Log In	Upgrade